stem cell trials

The Scientist looks at one such Houston-based purveyor that has been treating patients abroad for years with mesenchymal stem cells.

California’s stem cell agency unveiled a 5-year plan that includes starting 50 new clinical trials.

As researchers conduct the most rigorous human trials of cardiac cell therapies yet attempted, a clear picture of whether these treatments actually work is imminent.

An animated primer on the harvesting, growth, and administration of cardiac cells to heart attack patients

Researchers at the RIKEN Center for Developmental Biology will treat the first patient in its clinical trial testing an induced pluripotent stem cell-based treatment for age-related macular degeneration.

Adult sickle-cell patients have safely stopped taking their immunosuppressant medication thanks to a new type of blood stem-cell transplant.

Nearly three years after Geron shuttered its stem cell program, BioTime receives funding to relaunch a Phase 1 trial for spinal cord injury.

A committee at the University of Düsseldorf finds misconduct in cardiologist Bodo-Eckehard Strauer’s work.  

A company offering experimental stem-cell treatments will carry out its procedures in Mexico after the FDA warned that it would need approval to operate in the U.S.
 

Patient safety is paramount in regulating new stem cell treatments.

Two former Geron CEOs make a bid for the company’s defunct human embryonic stem cell business.

In a Phase I trial, researchers show that neural stem cells transplanted into humans can differentiate and begin producing myelin.

Japanese researchers are launching an iPS cell trial for an untreatable eye disease, challenging ongoing embryonic stem cell trials.